Surge since its inception has been focused on extending its outreach of branded generic formulations and microencapsulated APIs across the globe. Following its vision Surge expanded its marketing operations to various export territories initially for its branded generic formulations in Africa and Fareast. The challenges for the international markets have always been taken as an opportunity and Surge has now successfully established its market presence in Far-East, Asia, Central Asia & Africa for its branded generic formulations. The company has an independent international marketing department comprising of highly skilled and qualified professionals taking the company to new horizons.

Surge with the introduction of its premium quality microencapsulated APIs range in the form of coated pellets and coated granules manufactured under the latest microencapsulation technology from Germany, got phenomenal responses from the pharmaceutical formulation industry from domestic and international markets. Leading global API traders from the EU and South America have strategically collaborated with Surge for their customers in South & Central America and with unmatched product compliance and quality the multinational companies including the innovator preferred Surge for their source of formulations.  The company now exports its branded generics formulations and microencapsulated APIs to various semi-regulated markets like South & Central America, Central Asia, MENA as well as Eastern Europe.